Risk Factors for Selection of the L74I Reverse Transcriptase Mutation in Human Immunodeficiency Virus Type 1-Infected Patients
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00092-06
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2006
Authors
Publisher
American Society for Microbiology